Efficacy and safety of angiotensin receptor blockade are not modified by aspirin in patients with chronic heart failure: a cohort study from the Candesartan in Heart failure – Assessment of Reduction in Mortality and morbidity (CHARM) programme.

Authors :: Su Min Chang
Granger, Christopher B.
Johansson, Peter A.
Kosolcharoen, Peter
McMurray, John J. V.
Michelson, Eric L.
Murray, David R.
Olofsson, Bertil
Pfeffer, Marc A.
Solomon, Scott D.
Swedberg, Karl
Yusuf, Salim
Dunlap, Mark E.
Source :: European Journal of Heart Failure. Jul2010, Vol. 12 Issue 7, p738-745. 8p. 2 Diagrams, 2 Charts, 2 Graphs.
Publication Year :: 2010
Abstract: Aims: It is unknown whether there is an interaction between aspirin and angiotensin receptor blockers on outcomes in patients with heart failure (HF). [ABSTRACT FROM PUBLISHER]

Subjects :: *CHEMICAL inhibitors
*ANGIOTENSINS
*ASPIRIN
*CANDESARTAN
*HEART failure patients
*DRUG efficacy

Full Text Access

Tools